nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—Binding and entry of HIV virion—CD4—kidney cancer	0.0403	0.105	CbGpPWpGaD
Framycetin—Ulcerative keratitis—Erlotinib—kidney cancer	0.0386	0.073	CcSEcCtD
Framycetin—Nephrotoxicity—Everolimus—kidney cancer	0.0318	0.0601	CcSEcCtD
Framycetin—Impaired healing—Temsirolimus—kidney cancer	0.0314	0.0594	CcSEcCtD
Framycetin—Ototoxicity—Paclitaxel—kidney cancer	0.0283	0.0534	CcSEcCtD
Framycetin—Nerve injury—Paclitaxel—kidney cancer	0.026	0.0491	CcSEcCtD
Framycetin—Impaired healing—Everolimus—kidney cancer	0.0234	0.0442	CcSEcCtD
Framycetin—CXCR4—S1P3 pathway—FLT1—kidney cancer	0.0229	0.0594	CbGpPWpGaD
Framycetin—CXCR4—renal system—kidney cancer	0.0226	0.263	CbGeAlD
Framycetin—CXCR4—kidney—kidney cancer	0.0218	0.254	CbGeAlD
Framycetin—CXCR4—cortex of kidney—kidney cancer	0.0213	0.247	CbGeAlD
Framycetin—CXCR4—cardiac atrium—kidney cancer	0.0202	0.235	CbGeAlD
Framycetin—Impaired healing—Sunitinib—kidney cancer	0.0195	0.0369	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—PGK1—kidney cancer	0.0193	0.0501	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	0.0179	0.0466	CbGpPWpGaD
Framycetin—Nephropathy toxic—Everolimus—kidney cancer	0.0176	0.0333	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—CA9—kidney cancer	0.0164	0.0426	CbGpPWpGaD
Framycetin—Viral infection—Temsirolimus—kidney cancer	0.0151	0.0284	CcSEcCtD
Framycetin—CXCR4—Early Phase of HIV Life Cycle—CD4—kidney cancer	0.0148	0.0384	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—PAX6—kidney cancer	0.0134	0.0348	CbGpPWpGaD
Framycetin—Nephropathy toxic—Gemcitabine—kidney cancer	0.0118	0.0223	CcSEcCtD
Framycetin—Viral infection—Everolimus—kidney cancer	0.0112	0.0212	CcSEcCtD
Framycetin—Swelling—Temsirolimus—kidney cancer	0.0112	0.0211	CcSEcCtD
Framycetin—Secondary infection—Doxorubicin—kidney cancer	0.0102	0.0193	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—TCEB1—kidney cancer	0.00989	0.0257	CbGpPWpGaD
Framycetin—CXCR4—HIV Life Cycle—TCEB2—kidney cancer	0.00989	0.0257	CbGpPWpGaD
Framycetin—Nephropathy toxic—Paclitaxel—kidney cancer	0.00988	0.0187	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	0.00982	0.0255	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—IGF2—kidney cancer	0.0095	0.0247	CbGpPWpGaD
Framycetin—Viral infection—Sunitinib—kidney cancer	0.00935	0.0177	CcSEcCtD
Framycetin—Sensitisation—Doxorubicin—kidney cancer	0.0084	0.0159	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PAK1—kidney cancer	0.00804	0.0209	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ABCB1—kidney cancer	0.00775	0.0201	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—VEGFA—kidney cancer	0.00727	0.0189	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—KDR—kidney cancer	0.00723	0.0188	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—MAPK3—kidney cancer	0.00687	0.0179	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—TCEB2—kidney cancer	0.00683	0.0177	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—TCEB1—kidney cancer	0.00683	0.0177	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—KIT—kidney cancer	0.00666	0.0173	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—MAPK1—kidney cancer	0.00654	0.017	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	0.00634	0.0165	CbGpPWpGaD
Framycetin—Viral infection—Paclitaxel—kidney cancer	0.00628	0.0119	CcSEcCtD
Framycetin—Erythema—Temsirolimus—kidney cancer	0.00594	0.0112	CcSEcCtD
Framycetin—Erythema—Pazopanib—kidney cancer	0.0056	0.0106	CcSEcCtD
Framycetin—Anaphylactic shock—Temsirolimus—kidney cancer	0.00485	0.00916	CcSEcCtD
Framycetin—Infection—Temsirolimus—kidney cancer	0.00482	0.0091	CcSEcCtD
Framycetin—Swelling—Paclitaxel—kidney cancer	0.00467	0.00882	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.00466	0.0121	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—OR4C13—kidney cancer	0.00455	0.0118	CbGpPWpGaD
Framycetin—Infection—Pazopanib—kidney cancer	0.00454	0.00858	CcSEcCtD
Framycetin—Erythema—Everolimus—kidney cancer	0.00442	0.00835	CcSEcCtD
Framycetin—Erythema—Erlotinib—kidney cancer	0.00427	0.00806	CcSEcCtD
Framycetin—CXCR4—HIV Infection—PSMD7—kidney cancer	0.00421	0.0109	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—OR4C13—kidney cancer	0.00413	0.0107	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—ANXA1—kidney cancer	0.00393	0.0102	CbGpPWpGaD
Framycetin—Erythema—Sorafenib—kidney cancer	0.00384	0.00725	CcSEcCtD
Framycetin—Swelling—Capecitabine—kidney cancer	0.00383	0.00724	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—JUN—kidney cancer	0.00383	0.00994	CbGpPWpGaD
Framycetin—Erythema—Sunitinib—kidney cancer	0.00369	0.00698	CcSEcCtD
Framycetin—Infection—Everolimus—kidney cancer	0.00358	0.00677	CcSEcCtD
Framycetin—Hypersensitivity—Temsirolimus—kidney cancer	0.00357	0.00675	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—MTOR—kidney cancer	0.00353	0.00918	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—CD4—kidney cancer	0.00352	0.00916	CbGpPWpGaD
Framycetin—Erythema—Dactinomycin—kidney cancer	0.0035	0.0066	CcSEcCtD
Framycetin—Infection—Erlotinib—kidney cancer	0.00346	0.00653	CcSEcCtD
Framycetin—Pruritus—Temsirolimus—kidney cancer	0.00343	0.00648	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	0.00334	0.00869	CbGpPWpGaD
Framycetin—Viral infection—Doxorubicin—kidney cancer	0.00332	0.00628	CcSEcCtD
Framycetin—Diarrhoea—Temsirolimus—kidney cancer	0.00332	0.00627	CcSEcCtD
Framycetin—Pruritus—Pazopanib—kidney cancer	0.00323	0.00611	CcSEcCtD
Framycetin—Anaphylactic shock—Sorafenib—kidney cancer	0.00313	0.00592	CcSEcCtD
Framycetin—Diarrhoea—Pazopanib—kidney cancer	0.00313	0.00591	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00313	0.00812	CbGpPWpGaD
Framycetin—Infection—Sorafenib—kidney cancer	0.00311	0.00588	CcSEcCtD
Framycetin—Vomiting—Temsirolimus—kidney cancer	0.00308	0.00583	CcSEcCtD
Framycetin—Infection—Sunitinib—kidney cancer	0.00299	0.00566	CcSEcCtD
Framycetin—Erythema—Gemcitabine—kidney cancer	0.00296	0.0056	CcSEcCtD
Framycetin—Vomiting—Pazopanib—kidney cancer	0.00291	0.00549	CcSEcCtD
Framycetin—Nausea—Temsirolimus—kidney cancer	0.00288	0.00544	CcSEcCtD
Framycetin—Infection—Dactinomycin—kidney cancer	0.00283	0.00535	CcSEcCtD
Framycetin—CXCR4—Disease—CCBL1—kidney cancer	0.00278	0.00724	CbGpPWpGaD
Framycetin—Nausea—Pazopanib—kidney cancer	0.00271	0.00513	CcSEcCtD
Framycetin—Hypersensitivity—Vinblastine—kidney cancer	0.00267	0.00504	CcSEcCtD
Framycetin—Hypersensitivity—Everolimus—kidney cancer	0.00266	0.00502	CcSEcCtD
Framycetin—Pruritus—Everolimus—kidney cancer	0.00255	0.00482	CcSEcCtD
Framycetin—Anaphylactic shock—Vincristine—kidney cancer	0.00255	0.00482	CcSEcCtD
Framycetin—Infection—Vincristine—kidney cancer	0.00253	0.00478	CcSEcCtD
Framycetin—CXCR4—Disease—AMER1—kidney cancer	0.00252	0.00654	CbGpPWpGaD
Framycetin—Erythema—Paclitaxel—kidney cancer	0.00248	0.00469	CcSEcCtD
Framycetin—Diarrhoea—Vinblastine—kidney cancer	0.00248	0.00468	CcSEcCtD
Framycetin—Diarrhoea—Everolimus—kidney cancer	0.00247	0.00466	CcSEcCtD
Framycetin—Pruritus—Erlotinib—kidney cancer	0.00246	0.00465	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—OR4C13—kidney cancer	0.00244	0.00634	CbGpPWpGaD
Framycetin—Anaphylactic shock—Gemcitabine—kidney cancer	0.00242	0.00457	CcSEcCtD
Framycetin—Infection—Gemcitabine—kidney cancer	0.0024	0.00454	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—CD4—kidney cancer	0.0024	0.00623	CbGpPWpGaD
Framycetin—Diarrhoea—Erlotinib—kidney cancer	0.00238	0.0045	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—ANXA1—kidney cancer	0.00238	0.00619	CbGpPWpGaD
Framycetin—Hypersensitivity—Sorafenib—kidney cancer	0.00231	0.00436	CcSEcCtD
Framycetin—Vomiting—Vinblastine—kidney cancer	0.0023	0.00435	CcSEcCtD
Framycetin—Vomiting—Everolimus—kidney cancer	0.00229	0.00433	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—POMC—kidney cancer	0.00228	0.00593	CbGpPWpGaD
Framycetin—Hypersensitivity—Sunitinib—kidney cancer	0.00222	0.00419	CcSEcCtD
Framycetin—Pruritus—Sorafenib—kidney cancer	0.00222	0.00419	CcSEcCtD
Framycetin—Vomiting—Erlotinib—kidney cancer	0.00221	0.00418	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CA—kidney cancer	0.00215	0.00559	CbGpPWpGaD
Framycetin—Nausea—Vinblastine—kidney cancer	0.00215	0.00406	CcSEcCtD
Framycetin—Nausea—Everolimus—kidney cancer	0.00214	0.00405	CcSEcCtD
Framycetin—Diarrhoea—Sorafenib—kidney cancer	0.00214	0.00405	CcSEcCtD
Framycetin—Pruritus—Sunitinib—kidney cancer	0.00213	0.00403	CcSEcCtD
Framycetin—CXCR4—Disease—GPC3—kidney cancer	0.00211	0.00548	CbGpPWpGaD
Framycetin—Hypersensitivity—Dactinomycin—kidney cancer	0.0021	0.00397	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—LATS1—kidney cancer	0.00207	0.00539	CbGpPWpGaD
Framycetin—Nausea—Erlotinib—kidney cancer	0.00207	0.00391	CcSEcCtD
Framycetin—Diarrhoea—Sunitinib—kidney cancer	0.00206	0.0039	CcSEcCtD
Framycetin—Erythema—Capecitabine—kidney cancer	0.00204	0.00385	CcSEcCtD
Framycetin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00202	0.00382	CcSEcCtD
Framycetin—Infection—Paclitaxel—kidney cancer	0.00201	0.0038	CcSEcCtD
Framycetin—Vomiting—Sorafenib—kidney cancer	0.00199	0.00376	CcSEcCtD
Framycetin—CXCR4—Disease—ST3GAL2—kidney cancer	0.00195	0.00507	CbGpPWpGaD
Framycetin—Diarrhoea—Dactinomycin—kidney cancer	0.00195	0.00369	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—POMC—kidney cancer	0.00193	0.00501	CbGpPWpGaD
Framycetin—Vomiting—Sunitinib—kidney cancer	0.00192	0.00362	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—AKAP13—kidney cancer	0.00189	0.00491	CbGpPWpGaD
Framycetin—Hypersensitivity—Vincristine—kidney cancer	0.00188	0.00355	CcSEcCtD
Framycetin—Nausea—Sorafenib—kidney cancer	0.00186	0.00351	CcSEcCtD
Framycetin—CXCR4—Disease—SLC5A3—kidney cancer	0.00183	0.00475	CbGpPWpGaD
Framycetin—CXCR4—Disease—PGK1—kidney cancer	0.00183	0.00475	CbGpPWpGaD
Framycetin—Vomiting—Dactinomycin—kidney cancer	0.00181	0.00343	CcSEcCtD
Framycetin—CXCR4—Disease—LDHB—kidney cancer	0.00179	0.00466	CbGpPWpGaD
Framycetin—CXCR4—Disease—SFRP2—kidney cancer	0.00179	0.00466	CbGpPWpGaD
Framycetin—Nausea—Sunitinib—kidney cancer	0.00179	0.00338	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—AMER1—kidney cancer	0.00176	0.00458	CbGpPWpGaD
Framycetin—Diarrhoea—Vincristine—kidney cancer	0.00174	0.00329	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—AKAP13—kidney cancer	0.00171	0.00446	CbGpPWpGaD
Framycetin—Pruritus—Gemcitabine—kidney cancer	0.00171	0.00323	CcSEcCtD
Framycetin—Nausea—Dactinomycin—kidney cancer	0.00169	0.0032	CcSEcCtD
Framycetin—CXCR4—Disease—TCEB2—kidney cancer	0.00167	0.00435	CbGpPWpGaD
Framycetin—CXCR4—Disease—TCEB1—kidney cancer	0.00167	0.00435	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CD4—kidney cancer	0.00166	0.0043	CbGpPWpGaD
Framycetin—Diarrhoea—Gemcitabine—kidney cancer	0.00165	0.00313	CcSEcCtD
Framycetin—Infection—Capecitabine—kidney cancer	0.00165	0.00312	CcSEcCtD
Framycetin—Vomiting—Vincristine—kidney cancer	0.00162	0.00306	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—ITPR2—kidney cancer	0.00161	0.00417	CbGpPWpGaD
Framycetin—Vomiting—Gemcitabine—kidney cancer	0.00154	0.0029	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.00153	0.00398	CbGpPWpGaD
Framycetin—Nausea—Vincristine—kidney cancer	0.00151	0.00286	CcSEcCtD
Framycetin—Hypersensitivity—Paclitaxel—kidney cancer	0.00149	0.00282	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CER1—kidney cancer	0.00148	0.00384	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GPC3—kidney cancer	0.00148	0.00384	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ITPR2—kidney cancer	0.00146	0.00379	CbGpPWpGaD
Framycetin—Nausea—Gemcitabine—kidney cancer	0.00144	0.00271	CcSEcCtD
Framycetin—Pruritus—Paclitaxel—kidney cancer	0.00143	0.00271	CcSEcCtD
Framycetin—Diarrhoea—Paclitaxel—kidney cancer	0.00139	0.00262	CcSEcCtD
Framycetin—CXCR4—Disease—RPL14—kidney cancer	0.00136	0.00353	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ANXA1—kidney cancer	0.00135	0.0035	CbGpPWpGaD
Framycetin—Erythema—Doxorubicin—kidney cancer	0.00131	0.00248	CcSEcCtD
Framycetin—Vomiting—Paclitaxel—kidney cancer	0.00129	0.00243	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SFRP2—kidney cancer	0.00126	0.00327	CbGpPWpGaD
Framycetin—CXCR4—Disease—ITPR2—kidney cancer	0.00123	0.0032	CbGpPWpGaD
Framycetin—Hypersensitivity—Capecitabine—kidney cancer	0.00122	0.00231	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—ANXA1—kidney cancer	0.00122	0.00317	CbGpPWpGaD
Framycetin—Nausea—Paclitaxel—kidney cancer	0.0012	0.00227	CcSEcCtD
Framycetin—Pruritus—Capecitabine—kidney cancer	0.00118	0.00222	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—POMC—kidney cancer	0.00117	0.00303	CbGpPWpGaD
Framycetin—Diarrhoea—Capecitabine—kidney cancer	0.00114	0.00215	CcSEcCtD
Framycetin—Anaphylactic shock—Doxorubicin—kidney cancer	0.00107	0.00202	CcSEcCtD
Framycetin—Infection—Doxorubicin—kidney cancer	0.00106	0.00201	CcSEcCtD
Framycetin—Vomiting—Capecitabine—kidney cancer	0.00106	0.002	CcSEcCtD
Framycetin—CXCR4—Disease—PSMD7—kidney cancer	0.00103	0.00268	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKAP13—kidney cancer	0.00101	0.00263	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP2—kidney cancer	0.00101	0.00263	CbGpPWpGaD
Framycetin—Nausea—Capecitabine—kidney cancer	0.000987	0.00186	CcSEcCtD
Framycetin—CXCR4—Disease—SLC2A1—kidney cancer	0.000932	0.00242	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRB7—kidney cancer	0.000926	0.00241	CbGpPWpGaD
Framycetin—CXCR4—Disease—JUNB—kidney cancer	0.000925	0.0024	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITPR2—kidney cancer	0.000861	0.00224	CbGpPWpGaD
Framycetin—Hypersensitivity—Doxorubicin—kidney cancer	0.000789	0.00149	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CTNNA1—kidney cancer	0.000781	0.00203	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EIF4EBP1—kidney cancer	0.000776	0.00202	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HSPB1—kidney cancer	0.000776	0.00202	CbGpPWpGaD
Framycetin—Pruritus—Doxorubicin—kidney cancer	0.000758	0.00143	CcSEcCtD
Framycetin—CXCR4—Disease—CDKN2B—kidney cancer	0.000753	0.00196	CbGpPWpGaD
Framycetin—Diarrhoea—Doxorubicin—kidney cancer	0.000733	0.00138	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PSMD7—kidney cancer	0.000722	0.00188	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TSC1—kidney cancer	0.000722	0.00188	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ANXA1—kidney cancer	0.000722	0.00188	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FLT1—kidney cancer	0.000699	0.00182	CbGpPWpGaD
Framycetin—Vomiting—Doxorubicin—kidney cancer	0.000681	0.00129	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—POMC—kidney cancer	0.000659	0.00171	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUNB—kidney cancer	0.000648	0.00168	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PAK1—kidney cancer	0.000648	0.00168	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—kidney cancer	0.000636	0.0012	CcSEcCtD
Framycetin—CXCR4—Disease—HIF1A—kidney cancer	0.000602	0.00156	CbGpPWpGaD
Framycetin—CXCR4—Disease—TSC2—kidney cancer	0.000601	0.00156	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—POMC—kidney cancer	0.000598	0.00156	CbGpPWpGaD
Framycetin—CXCR4—Disease—APC—kidney cancer	0.00053	0.00138	CbGpPWpGaD
Framycetin—CXCR4—Disease—KIT—kidney cancer	0.00053	0.00138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF2—kidney cancer	0.00053	0.00138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN2B—kidney cancer	0.000527	0.00137	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1R—kidney cancer	0.000512	0.00133	CbGpPWpGaD
Framycetin—CXCR4—Disease—BRAF—kidney cancer	0.000499	0.0013	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RAF1—kidney cancer	0.000493	0.00128	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—kidney cancer	0.000487	0.00127	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—kidney cancer	0.000442	0.00115	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIF1A—kidney cancer	0.000422	0.0011	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TSC2—kidney cancer	0.000421	0.00109	CbGpPWpGaD
Framycetin—CXCR4—Disease—RAF1—kidney cancer	0.000416	0.00108	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB2—kidney cancer	0.000412	0.00107	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTOR—kidney cancer	0.000406	0.00106	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD4—kidney cancer	0.000406	0.00105	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—kidney cancer	0.000403	0.00105	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—kidney cancer	0.000403	0.00105	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1B—kidney cancer	0.000381	0.000991	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KIT—kidney cancer	0.000371	0.000965	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APC—kidney cancer	0.000371	0.000965	CbGpPWpGaD
Framycetin—CXCR4—Disease—CTNNB1—kidney cancer	0.00036	0.000936	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK3—kidney cancer	0.000356	0.000924	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—POMC—kidney cancer	0.000354	0.000919	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—kidney cancer	0.000351	0.000913	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BRAF—kidney cancer	0.000349	0.000907	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK1—kidney cancer	0.000338	0.00088	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—kidney cancer	0.000323	0.000841	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—kidney cancer	0.00032	0.000831	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK3—kidney cancer	0.0003	0.00078	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—kidney cancer	0.000294	0.000763	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—kidney cancer	0.000292	0.000758	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RAF1—kidney cancer	0.000291	0.000758	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RELA—kidney cancer	0.00029	0.000754	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—kidney cancer	0.000288	0.00075	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK1—kidney cancer	0.000285	0.000742	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MTOR—kidney cancer	0.000285	0.00074	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—kidney cancer	0.00027	0.000701	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1B—kidney cancer	0.000267	0.000694	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—kidney cancer	0.000261	0.000679	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—kidney cancer	0.000255	0.000662	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUN—kidney cancer	0.000254	0.000661	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTNNB1—kidney cancer	0.000252	0.000656	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—kidney cancer	0.000248	0.000644	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—kidney cancer	0.000246	0.000639	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—kidney cancer	0.000222	0.000577	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK3—kidney cancer	0.00021	0.000546	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—kidney cancer	0.000204	0.000531	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK1—kidney cancer	0.0002	0.00052	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—kidney cancer	0.000189	0.000491	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—kidney cancer	0.000173	0.000451	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—kidney cancer	0.000168	0.000436	CbGpPWpGaD
